Cingulate Inc. (CING)
NASDAQ: CING · Real-Time Price · USD
4.225
+0.545 (14.82%)
Aug 14, 2025, 1:42 PM - Market open
Cingulate Market Cap
Cingulate has a market cap or net worth of $22.24 million as of August 14, 2025. Its market cap has increased by 499.17% in one year.
Market Cap
22.24M
Enterprise Value
15.67M
1-Year Change
499.17%
Ranking
Category
Stock Price
$4.23
Market Cap Chart
Since the IPO on December 8, 2021, Cingulate's market cap has decreased from $64.29M to $22.24M, a decrease of -65.40%. That is a compound annual growth rate of -25.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 19.37M | 19.02% |
| Dec 31, 2024 | 16.28M | 127.09% |
| Dec 29, 2023 | 7.17M | -36.62% |
| Dec 30, 2022 | 11.31M | -63.77% |
| Dec 31, 2021 | 31.21M | -51.44% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 571.23B |
| Johnson & Johnson | 419.15B |
| AbbVie | 349.50B |
| Abbott Laboratories | 229.58B |
| UnitedHealth Group | 229.23B |
| Novartis AG | 228.69B |
| AstraZeneca | 227.85B |
| Novo Nordisk | 222.88B |